Denosumab for Breast Cancer With Bone Mets
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Denosumab
Sponsor: M.D. Anderson Cancer Center
Collaborators: Amgen